Quest Diagnostics Incorporated (DGX)

Quest Diagnostics (NYSE:DGX) Sets New 12-Month High – Here’s What Happened

Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology

Is it the Right Time to Retain DGX Stock in Your Portfolio?

Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?

Quest Diagnostics Incorporated (NYSE:DGX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Quest Diagnostics (DGX) Upgraded to Buy: Here's Why

WHOOP Makes Advanced Labs Available Without a Wearable Membership

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics typically performs between 30 and 40 cyclospora tests a day. Now it's processing more than 1,500.

Quest Diagnostics CEO: AI is helping patients understand their doctors

Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates

Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?

Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026

Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Why Quest Diagnostics Stock Climbed This Past Week

Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice